Quiz: Epidemiology and Prognosis in Ovarian Cancer

Article

How much do you know about the epidemiology and prognosis of ovarian cancer? Here's your chance to find out.

In our August ovarian cancer quiz, you’ll get a chance to test your knowledge on the epidemiology and prognosis of this disease. Here’s your first question:

1.  Pain is independently associated with overall survival time among women with recurrent ovarian cancer.

A.True

B.False


Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Future findings from a translational analysis of the OVATION-2 trial may corroborate prior clinical data with IMNN-001 in advanced ovarian cancer.
Approximately 10% of patients discontinued treatment with avutometinib/defactinib due to toxicity in the phase 2 RAMP 201 trial.
Response rates appeared to be higher with avutometinib plus defactinib vs avutometinib alone in the phase 2 RAMP 201 study.